Company news
Renalytix PLC news in 2023
Renalytix PLC's news releases, calls and decks from 2023, newest first.
Grant of Share Options
November 23, 2023
Publication of Annual Report 2023 & Notice of AGM
November 17, 2023
Renalytix Reports Financial Results for Q1 FY2024
November 14, 2023
Notice of Results
November 7, 2023
Announcement of AGM and Publication of AR
October 30, 2023
Directorate change
October 24, 2023
US Patent Office Allows Patent Claims for IP
October 6, 2023
Medicare prices kidneyintelX.dkd at $950
October 3, 2023
Renalytix Reports Full Year Fiscal 2023 Results
September 28, 2023
Payer coverage expansion of KidneyIntelX
September 22, 2023
Appointment of Chief Business Officer
September 7, 2023
Business Update
August 21, 2023
RSU vesting for employees
August 3, 2023
Vector Pharma Middle East Distribution Agreement
July 21, 2023
Issue of Shares - Replacement
July 17, 2023
KidneyIntelX evidence presented at ADA
July 7, 2023
FDA Approves KidneyIntelX.dkd™
June 30, 2023
Presentation of Scientific Data
June 15, 2023
Financial Results for Q3 of Fiscal Year 2023
June 9, 2023
EVERSANA® partnership for KidneyIntelX
May 25, 2023
Expansion of insurance coverage for KidneyIntelX
May 22, 2023
Notice of GM and Posting of Circular
May 11, 2023
Real-World Evidence Shows KidneyIntelXT Utility
April 19, 2023
Positive Data Release at NKF Conference
April 12, 2023
Business Update - Replacement
March 27, 2023
Second Price Monitoring Extn
March 21, 2023
Statement re. Silicon Valley Bank
March 13, 2023
Director/PDMR Shareholding
February 10, 2023
RENX to Participate in the BTIG MedTech Conference
February 9, 2023
Renalytix announces a c.$20.3m private placement
February 8, 2023
Renalytix and Partners Awarded $10 Million Grant
January 26, 2023
Price Monitoring Extension
January 9, 2023